Intraoperative augmented imaging for surgery.
FDA: 510(k) K203550, Class II, April 2021; K231344, August 2023, sterilisation change only (confirmed).
CE: CE mark under MDR announced December 2022; class and notified body not public (vendor-claimed).
AI function: no separate FDA clearance found for the ‘colorectal AI mode’ (confirmed: FDA database checked, November 2026).
Liu et al., Surg Endosc 2023 (n=67, vendor-funded): perfusion seen in 97.5-100% of robotic and laparoscopic cases, no adverse events.
Skinner et al., Dis Colon Rectum 2024 (n=40, vendor-funded): imaging changed the surgical decision in 17.5% of left-sided colorectal resections.
Not found in this research pass — verify before publishing.
The vendor claims over 2,000 surgical cases and availability in 17+ countries, without a public list of sites. The first case with the AI mode was done at Ohio State University Wexner Medical Center (US) in December 2022.
Fits between existing laparoscope and camera; overlays on standard monitors; no DICOM/HL7/FHIR details found (vendor-claimed).
– The cleared indication covers imaging only; the regulatory status of the AI features is unclear.
– Evidence is small and mostly vendor-funded feasibility work; no independent ActivSight study found.
– No data yet showing fewer anastomotic leaks or better patient outcomes.
– Not for stand-alone bile duct imaging; use with white light and cholangiography when indicated.
– Adoption figures are vendor-declared; no named European site in routine use.
HomepageStudy (vendor-funded) — Liu YZ et al., LSCI utility and usability in robotic and laparoscopic surgery, Surgical Endoscopy, 2023 https://pmc.ncbi.nlm.nih.gov/articles/PMC9483347/ Regulator — FDA 510(k) K231344, ActivSight Intraoperative Imaging System (Innolitics mirror of FDA record), August 2023 https://fda.innolitics.com/device/K231344 Regulator — FDA, K231344 clearance letter and 510(k) summary, accessdata.fda.gov, August 2023 https://www.accessdata.fda.gov/cdrh_docs/pdf23/K231344.pdf Study (vendor-funded) — Skinner GC et al., Clinical utility of LSCI in left-sided colorectal resections, Diseases of the Colon & Rectum, 2024 https://doi.org/10.1097/dcr.0000000000003098
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.
